| 000 | 01633 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516145040.0 | ||
| 264 | 0 | _c20140515 | |
| 008 | 201405s 0 0 eng d | ||
| 022 | _a1651-226X | ||
| 024 | 7 |
_a10.3109/0284186X.2013.786839 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKelderman, Sander | |
| 245 | 0 | 0 |
_aIpilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O). _h[electronic resource] |
| 260 |
_bActa oncologica (Stockholm, Sweden) _cNov 2013 |
||
| 300 |
_a1786-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aIpilimumab |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aNetherlands |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aUveal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aUveal Melanoma |
| 700 | 1 | _avan der Kooij, Monique K | |
| 700 | 1 | _avan den Eertwegh, Alfons J M | |
| 700 | 1 | _aSoetekouw, Patricia M M B | |
| 700 | 1 | _aJansen, Rob L H | |
| 700 | 1 | _avan den Brom, Rob R H | |
| 700 | 1 | _aHospers, Geke A P | |
| 700 | 1 | _aHaanen, John B A G | |
| 700 | 1 | _aKapiteijn, Ellen | |
| 700 | 1 | _aBlank, Christian U | |
| 773 | 0 |
_tActa oncologica (Stockholm, Sweden) _gvol. 52 _gno. 8 _gp. 1786-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3109/0284186X.2013.786839 _zAvailable from publisher's website |
| 999 |
_c22690280 _d22690280 |
||